| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2874959 | The Annals of Thoracic Surgery | 2011 | 8 Pages |
Abstract
Increased circulating fibrocyte levels correlate with the development of BOS after lung transplantation and positively correlate with advancing BOS stage. Quantification of circulating fibrocytes could serve as a novel biomarker and possible therapeutic target for BOS development in lung transplant patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Damien J. MD, Marie D. BS, Abbas MD, David A. BA, Brett A. Strieter, Ling BS, Mark MD, Irving L. MD, Robert M. MD, Christine L. MD,